HMB-002, an antibody-based experimental treatment for von Willebrand disease (VWD) currently in early clinical testing, boosted levels of the…
Articles by Marisa Wexler MS
A combination of the medicines eltrombopag and cyclosporine A may be effective for controlling immune thrombocytopenia (ITP) that doesn’t…
A recent case report highlights the challenges of performing surgery in a patient with more than one bleeding disorder. Two…
The approved immune thrombocytopenia (ITP) treatment Doptelet (avatrombopag) may be able to be repurposed to treat certain bone…
Use of the experimental cell therapy QT-019B showed promise for people with treatment-resistant immune thrombocytopenia (ITP) in early clinical…
Electrical stimulation of nerves that control automatic bodily functions, administered twice daily through a device worn over the ear, may…
Scientists in China have discovered that the proteins RNF5 and DNAJC21 — the latter encoded by the DNAJC21 gene —…
Researchers have developed two novel antibody-based therapies that may be used to treat antibody-mediated autoimmune diseases such as immune…
An arm of the European Medicines Agency (EMA) is recommending that Wayrilz (rilzabrutinib) be approved to treat adults with…
Researchers created an experimental treatment for von Willebrand disease (VWD) type 1 that aims to stabilize the protein whose…